Comparing Low-Dose Carvedilol Continuous Manufacturing by Solid and Liquid Feeding in Self-Emulsifying Delivery Systems via Hot Melt EXtrusion (SEDEX)
Pharmaceuticals · 28.09.2024 · 17 (10) · 1290
DOI: 10.3390/ph17101290 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceuticals, online erschienen am 28.09.2024. Verfasst von Ožbej Zupančič und 5 weiteren Autor:innen. Beteiligte Einrichtung: Research Center Pharmaceutical Engineering GmbH (RCPE), Inffeldgasse 13, 8010 Graz, Austria. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Austrian Federal Ministry of Climate Action, Environment, Energy, Mobility, Innovation, and Technology.
Abstract (Originalsprache)
Background/Objectives: This study compared two pilot scale continuous manufacturing methods of solid self-emulsifying drug delivery systems (SEDDSs) via hot melt extrusion (HME).
Methods
A model poorly water-soluble drug carvedilol in low dose (0.5–1.0% w/w) was processed in HME either in a conventional powder form or pre-dissolved in the liquid SEDDS.
Results
HME yielded a processable final product with up to 20% w/w SEDDS. Addition of carvedilol powder resulted in a non-homogeneous drug distribution in the extrudates, whereas a homogeneous drug distribution was observed in pre-dissolved carvedilol. SEDDSs were shown to have a plasticizing effect, reducing the HME process torque up to 50%. Compatibility between excipients and carvedilol in the studied ratios after HME was confirmed via DSC and WAXS, demonstrating their amorphous form. Solid SEDDSs with Kollidon® VA64 self-emulsified in aqueous medium within 15 min with mean droplet sizes 150–200 nm and were independent of the medium temperature, whereas reconstitution of Soluplus® took over 60 min and mean droplet size increased 2-fold from 70 nm to 150 nm after temperature increased from 25 °C to 37 °C, indicating emulsion phase inversion at cloud point.
Conclusions
In conclusion, using Kollidon® VA64 and pre-dissolved carvedilol in SEDDS has shown to yield a stabile HME process with a homogenous carvedilol content in the extrudate.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Research Center Pharmaceutical Engineering GmbH (RCPE), Inffeldgasse 13, 8010 Graz, Austria.
- Institute of Process and Particle Engineering, Graz University of Technology, Inffeldgasse 13/3, 8010 Graz, Austria.
ORCID-Profile: Josip Matić, Aygün Doğan, Alessio Gaggero, Amrit Paudel
Förderung
- Austrian Federal Ministry of Climate Action, Environment, Energy, Mobility, Innovation, and Technology
Zitieren
APA
Zupančič, O., Matić, J., Doğan, A., Gaggero, A., Khinast, J., & Paudel, A. (2024). Comparing Low-Dose Carvedilol Continuous Manufacturing by Solid and Liquid Feeding in Self-Emulsifying Delivery Systems via Hot Melt EXtrusion (SEDEX). Pharmaceuticals, 17(10), 1290. https://doi.org/10.3390/ph17101290
Vancouver
Zupančič O, Matić J, Doğan A, Gaggero A, Khinast J, Paudel A. Comparing Low-Dose Carvedilol Continuous Manufacturing by Solid and Liquid Feeding in Self-Emulsifying Delivery Systems via Hot Melt EXtrusion (SEDEX). Pharmaceuticals. 2024;17(10):1290. doi:10.3390/ph17101290
BibTeX
@article{Zupani2024,
author = {Zupančič, Ožbej and Matić, Josip and Doğan, Aygün and Gaggero, Alessio and Khinast, Johannes and Paudel, Amrit},
title = {Comparing Low-Dose Carvedilol Continuous Manufacturing by Solid and Liquid Feeding in Self-Emulsifying Delivery Systems via Hot Melt EXtrusion (SEDEX)},
journal = {Pharmaceuticals},
year = {2024},
volume = {17},
number = {10},
pages = {1290},
doi = {10.3390/ph17101290}
}
EUVIMED